MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Clinical Assessment Of Dysautonomia And REM Sleep Behavior Disorders in Essential Tremor

    S. Sellami, N. Farhat, N. Bouattour, KS. Moalla, S. Daoued, S. Sakka, M. Damak, C. Mhiri (Sfax, Tunisia)

  • Clinical benefit of Opicapone in patients with different Parkinson disease phenopytes. The OPTIMO study

    MR. Luquin, C. Martin, I. Tegel, I. Pijuan, C. Moreno (Pamplona, Spain)

  • Clinical characteristics and Brain atrophy pattern in the prospective multicenter cohort of Progressive Supranuclear Palsy

    S. Lee, R. Kim, B. Jin, H. Kim, EJ. Yoon, YK. Kim, JH. Shin, HJ. Kim, JY. Lee (Seoul, Republic of Korea)

  • Clinical Characteristics and Management Practices of Pediatric Status Dystonicus

    K. Chesky, J. Gill, S. Thomas, M. Hull (Houston, USA)

  • Clinical characteristics associated with early discontinuation of Levodopa-Carbidopa Intestinal Gel infusion in patients with advanced Parkinson Disease.

    D. Rivero-Rodríguez, M. Morales-Casado, G. Tabar-Comellas, A. Diezma-Martín, P. Quintana-Castro, M. Ennazeh, N. López-Ariztegui (Toledo, Spain)

  • Clinical characteristics of movement disorders associated with multiple sclerosis patients: A cross sectional preliminary single center results.

    MM. Meshref, AF. El-Adawy, FM. Mansour, MH. Moawad, MEL. Elmasry, HG. Gad (Cairo, Egypt)

  • Clinical correlates of apathy in Parkinson´s disease

    J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)

  • Clinical Correlation of Double Oscillatory Peaks in Parkinson’s Disease with Deep Brain Stimulation

    W. Saengphatrachai, S. Akkus, J. Jimenez-Shahed (New York, USA)

  • Clinical differentiation between dystonic tremor and Parkinson’s disease based on tremor characteristics

    T. Tsuboi, K. Sawada, S. Hoshino, M. Higuchi, M. Muto, Y. Ito, M. Hashida, T. Ishizaki, S. Kato, D. Nakatsubo, T. Tsugawa, S. Maesawa, M. Sato, K. Hiraga, T. Uematsu, D. Tamakoshi, D. Fukushima, M. Suzuki, R. Saito, M. Katsuno (Nagoya, Japan)

  • Clinical effectiveness and safety of staged-bilateral MRgFUS for treating essential tremor, a literature review

    E. Natera Villalba, S. Paschen, M. Del Alamo, R. Martinez Fernandez, AK. Helmers (Madrid, Spain)

  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #23559 (not found)
  • #24483 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley